News Image

Agenus Corporate Update and First Quarter 2022 Financial Report

Provided By Globe Newswire

Last update: May 10, 2022

LEXINGTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today provided a corporate update and reported financial results for the first quarter 2022.

Read more at globenewswire.com

AGENUS INC

NASDAQ:AGEN (7/11/2025, 8:00:00 PM)

After market: 6.92 -0.14 (-1.98%)

7.06

+1.14 (+19.26%)



Find more stocks in the Stock Screener

Follow ChartMill for more